Express Pharma
Home  »  Latest Updates  »  Canada subsidiary of Natco Pharma in settlement agreement with Celgene for onco drug

Canada subsidiary of Natco Pharma in settlement agreement with Celgene for onco drug

The terms of the agreement are confidential as per the agreement

0 649
Read Article

Natco Pharma informed that its Canadian subsidiary has entered into a settlement agreement with biopharma firm Celgene (part of Bristol-Myers Squibb) for Lenalidomide capsules.

Lenalidomide is used to treat various types of cancers. It works by slowing or stopping the growth of cancer cells.

The company informed this in a regulatory filing. The terms of the agreement are confidential as per the agreement, the company added.

Leave A Reply

Your email address will not be published.